VanEck Vectors Net Asset

BBH -- USA Etf  

USD 132.32  0.61  0.46%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Net Asset Analysis

Net Asset is current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assest is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
VanEck Vectors 
Net Asset 
 = 
Current Market Value 
Current Liabilities 
 = 
492.86 M

About Net Asset

Net Asset is the value used in calulating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formullay that uses closing prices of all positions in the fund's portfolio.
Compare to competition
Based on recorded statements VanEck Vectors Biotech ETF has Net Asset of 492.86 M. This is 53.37% higher than that of the Van Eck family, and significantly higher than that of Sector category, The Net Asset for all etfs is 44.54% higher than the company.

Did you try this?

Run Chance of Distress Now

   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Chance of Distress

VanEck Vectors Institutional Holders

Current Institutional Investors

Security TypeSharesValue
Ubs Group AgFund Units74.7 K9 M
Susquehanna International Group LlpPut Options11.7 K1.4 M
Susquehanna International Group LlpCall Options10.6 K1.3 M

Asset Allocation

Fund Instrument Allocation for VanEck Vectors

The fund invests 100.0% of asset under management in tradable equity instruments, with the rest of investments concentrated in .
 Value 
      Instrument Type 

Fundamental Indicators

Current VanEck Vectors financial ratios



 
Search macroaxis.com